In one of the biggest studies to date, Tolkach and colleagues evaluated PSMA expression in the tumour endothelium (via immunohistochemistry) of 315 breast cancer patients with invasive non-special type carcinoma (NST) and lobular carcinoma. Here, FOLH1 is linked to breast carcinoma.